Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome

NCT00763893 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

303

Enrollment

OTHER

Sponsor class

Stopped A similar publication has been released, suggesting a beneficial effect of sartans, and only 15 patients remained to be seen for their visit at 36 months.

Conditions

Marfan Syndrome

Interventions

DRUG: placebo
DRUG: Losartan

Sponsor

Assistance Publique - Hôpitaux de Paris